Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Hematology
Published in: BMC Hematology 1/2013

Open Access 01-12-2013 | Editorial

BMC Blood Disorders becomes BMC Hematology: evolving along with the hematology field

Author: Christna Chap

Published in: BMC Hematology | Issue 1/2013

Login to get access

Abstract

This Editorial marks the launch of BMC Hematology, formerly known as BMC Blood Disorders, within the BMC series of journals published by BioMed Central. The scope of BMC Hematology encompasses basic, experimental and clinical research related to hematology. In this Editorial we will discuss the rationale behind this relaunch and how, as an open access journal providing unrestricted and free access to scientific and scholarly work, BMC Hematology will help disseminate research in the hematology field in a freely-accessible manner.
Literature
1.
2.
3.
4.
5.
6.
Godlee F: Making reviewers visible: openness, accountability, and credit. JAMA. 2002, 287: 2762-2765. 10.1001/jama.287.21.2762.CrossRefPubMed
7.
Pöschl U: Multi-stage open peer review: scientific evaluation integrating the strengths of traditional peer review with the virtues of transparency and self-regulation. Front Comput Neurosci. 2012, 6: 33-CrossRefPubMedPubMedCentral
8.
9.
Laakso M, Björk B-C: Anatomy of open access publishing: a study of longitudinal development and internal structure. BMC Med. 2012, 10: 124-10.1186/1741-7015-10-124.CrossRefPubMedPubMedCentral
10.
11.
12.
13.
14.
15.
Longo DL: An interview with Dan L. Longo, Section Editor of the Malignant hematological diseases section. BMC Hematology. 2013, 13: 2-10.1186/2052-1839-13-2.
Metadata
Title
BMC Blood Disorders becomes BMC Hematology: evolving along with the hematology field
Author
Christna Chap
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Hematology / Issue 1/2013
Electronic ISSN: 2052-1839
DOI
https://doi.org/10.1186/2052-1839-13-1

Other articles of this Issue 1/2013

BMC Hematology 1/2013 Go to the issue

Case report

Common variable immunodeficiency unmasked by treatment of immune thrombocytopenic purpura with Rituximab

Editorial

An interview with Dan L. Longo, Section Editor of the Malignant hematological diseases section

Research article

Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network

Research article

Prevalence and related factors of anemia in HAART-naive HIV positive patients at Gondar University Hospital, Northwest Ethiopia

Research article

Thiopurine methyltransferase genotyping in Palestinian childhood acute lymphoblastic leukemia patients

Research article

An etiological reappraisal of pancytopenia - largest series reported to date from a single tertiary care teaching hospital

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits